SkinHealth Systems Inc. Class A Common Stock (SKIN) is a publicly traded Consumer Defensive sector company. As of July 7, 2026, SKIN trades at $1.16 with a market cap of $94.06M and a P/E ratio of -9.13. SKIN moved +49.03% today. Year to date, SKIN is -47.21%; over the trailing twelve months it is -66.89%. Its 52-week range spans $0.55 to $2.69. Analyst consensus is buy with an average price target of $1.33. Rallies surfaces SKIN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for SKIN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.16 |
| Market Cap | $94.06M |
| P/E Ratio | -9.13 |
| EPS | $-0.08 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.69 |
| 52-Week Low | $0.55 |
| Volume | 61.48M |
| Avg Volume | 0 |
| Revenue (TTM) | $300.79M |
| Net Income | $-9.52M |
| Gross Margin | 65.28% |
3 analysts cover SKIN: 0 strong buy, 1 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.33.